Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Hsiehs Biotech Singapore Pte Ltd. is a Singaporean private company that provides research and development services of raw material production.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Stemcell Technologies, Inc. wholesales medical and hospital equipment. Its products include cell culture media and supplements, cell isolation products, primary and cultured cells, cell storage media, matrices and substrates, and cytokines. The firm offers contact assay services, custom solutions, product and scientific support, standardization tools, training programs, and science communication services. The company was founded by Allen Eaves in 1993 and is headquartered in Tukwila, WA.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Maxim Pharmaceuticals a biopharmaceutical company develops cancer therapeutics. Its lead drug candidate, Ceplene, is in a phase III clinical trial as a remission maintenance therapy for patients with acute myeloid leukemia, a form of adult leukemia.

Meiji Co., Ltd. produces and sells milk, dairy, confectioneries, and food. Its products include cheese, ice cream, chocolate, infant formula, whey protein, beauty supplements, and yogurt. The company was founded on December 21, 1917 and is headquartered in Tokyo, Japan.

User Experience Monitoring

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Microbio Co., Ltd. engages in the research, development, manufacture, and sale of new drugs and healthcare products. The company also supplies raw materials to pharmaceutical companies in Taiwan. Its major products include health food, herbal products, botanical drugs, and disease prevention and nutrients supplements. The company was founded in May 3, 2000 and is headquartered in Taipei, Taiwan.

Beijing Dingcheng Peptide Source Biotechnology Co., Ltd., established on 2014-03-26, Business scope includes biological,Pharmaceutical technology development,technology transfer,technical consulting,Technical Services;Sales of biological reagents(Free of Hazardous Chemicals,medicine).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Tianjin Stam Biotechnology Co., Ltd., established on 2013-03-06, Business scope includes licensed projects:Production of Class II Medical Devices[Branch operation];feed production[Branch operation];Food Internet Sales;food sales;Veterinary drug business;Veterinary drug production[Branch operation];pet keeping[Branch operation];Feed additive production[Branch operation].(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Development of Human Gene Diagnosis and Therapy Technology;Human stem cell technology development and application;Feed Additive Sales;Pet food and supplies retail;Pet Food and Supplies Wholesale;Labor service(Does not include labor dispatch);Manufacturing of daily necessities[Branch operation];daily mask(non-medical)Sales;Medical Mask Retail;Wholesale medical masks;Personal Hygiene Sales;Sales of hygiene products and single-use medical products;Sales of special labor protection products;Wholesale of protective equipment for medical staff;Sales of daily chemical products;Manufacturing of daily chemical products[Branch operation];Daily miscellaneous goods sales;internet sales(Except for products that require a license for sale);Sales of Class II Medical Devices;Sales of Class I Medical Devices;Production of Class I Medical Devices[Branch operation];pet service(No Animal Treatment);Food Internet Sales(Only sell prepackaged food);Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France.

SMT Bio Co., Ltd. is a company headquartered in Seoul, the South Korea, specializing in commercial physical and biological research. It was founded in 2015. Yong-Yoon Jung is currently the CEO of the firm.

Ildong Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicines, ingredients for medicines, health supplements and special nutritional products. Its products include vitamins, antibiotics, gastric ulcer medicine, peptic ulcerative agents, and diet pills. The company was founded on August 1, 2016 and is headquartered in Seoul, South Korea.

Jiangsu Haoke Biological Engineering Co., Ltd., established on 2016-04-28, Business scope includes technology research and development of biotechnology and biological products,technology transfer,technical consulting,Technical Services;blood products(animal serum)and laboratory reagents(except chemical products)production,Sales;one type,Production and sales of Class II medical devices;laboratory instrument(Does not include measuring instruments),plastic products,Chemical raw materials and their products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,Civil Explosives,precursor chemicals),Instrumentation,Sales and after-sales of electronic products,Technical Services;Business Information Consulting and Services(Does not include investment advice);Venue and Warehouse Leasing;Property Management and Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Import and export agency;Import and export;Technology Import and Export;Import and export of goods managed by state trade;Food import and export;Warehousing services for customs-supervised goods(Free of Hazardous Chemicals)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guangzhou Pusen Biotechnology Co., Ltd., established on 2018-04-18, Business scope includes medical research and experimental development;Engineering and Technology Research and Experimental Development;R&D and application of cell technology;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biomass Energy Technology Services;R&D and application of cell technology;Research and development of biopesticide technology;Bio-organic fertilizer research and development;Bio-feed R&D;Research and development of bio-based materials technology;Biochemical product technology research and development;R&D of industrial enzyme preparations;Fermentation process optimization technology research and development;Biomass liquid fuel production process research and development;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Research and development of bio-based material polymerization technology;Agricultural Science Research and Experimental Development;Natural science research and experimental development;Cosmetics Wholesale;Cosmetics Retail;Health food sales;Sales of formula food for special medical purposes